Literature DB >> 12540420

Low-dose unenhanced multidetector CT of patients with suspected renal colic.

Denis Tack1, Stavroula Sourtzis, Isabelle Delpierre, Viviane de Maertelaer, Pierre Alain Gevenois.   

Abstract

OBJECTIVE: This study is designed to assess the intraobserver and interobserver agreements and the diagnostic performances of low-dose unenhanced multidetector CT (MDCT) in patients with suspected renal colic. SUBJECTS AND METHODS: The study included 106 patients who underwent unenhanced MDCT with 4 x 2.5 mm collimation, 120 kVp, 30 mAs, and, if necessary, additional focused acquisitions at 60 or 120 mAs on areas with an equivocal ureteral stone or with significant image noise. The effective radiation dose was computer-simulated with software based on the Monte Carlo model and International Commission on Radiological Protection recommendations. CT scans were archived and independently reviewed by three radiologists during two interpretation sessions on a workstation with three dimensions functions. Intraobserver and interobserver agreements were calculated with the kappa statistics. Accuracy for detection of ureteral stone on low-dose MDCT was calculated by comparison with combined clinical (stone passage), surgical (stone retrieval, extracorporeal shock wave lithotripsy), biologic (urinalysis, urine culture), and other imaging (excretory urography, standard-dose MDCT, follow-up sonography, and abdominal radiography) findings or by evidence for an alternative diagnosis.
RESULTS: Ureteral stones were present in 38 (36%) of 106 patients. Thirty-six of 38 ureteral stones were detected by low-dose MDCT. From reviewer to reviewer, the number of true-positive, false-positive, true-negative, and false-negative findings ranged, respectively, from 34 to 36, 1 to 4, 64 to 68, and 2 to 4. The corresponding sensitivity, specificity, and accuracy ranged from 89.5% to 94.7%, from 94.1% to 100%, and from 93.4% to 98.1%, respectively. The intraobserver and interobserver agreements were excellent, with kappa values ranging from 0.87 to 0.98. In 13 patients, an alternative diagnosis explaining the patient's symptoms was proposed by all reviewers using images obtained at 30 mAs. No additional or alternative diagnosis was found at standard dose. At 30 mAs, the mean effective dose was 1.2 mSv in men and 1.9 mSv in women. Additional acquisitions at 60 mAs, all focused on the lower pelvis, were acquired in 20 patients, but the corresponding images were needed by the reviewers for only six of them. The acquisitions at 60 mAs were responsible for an additional mean effective dose of 0.5 in men and 0.8 mSv in women.
CONCLUSION: Our study shows that low-dose unenhanced MDCT is appropriate for the diagnosis of ureteral stones, and that it provides excellent intraobserver and interobserver agreements and does not obscure alternative diagnoses.

Entities:  

Mesh:

Year:  2003        PMID: 12540420     DOI: 10.2214/ajr.180.2.1800305

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  40 in total

1.  Negative predictive value of intravenous contrast-enhanced CT of the abdomen for patients presenting to the emergency department with undifferentiated upper abdominal pain.

Authors:  Hyungjoo Ham; Matthew D F McInnes; Michael Woo; Sylvie Lemonde
Journal:  Emerg Radiol       Date:  2011-11-10

2.  The presence of microscopic hematuria detected by urine dipstick test in the evaluation of patients with renal colic.

Authors:  A Argyropoulos; A Farmakis; K Doumas; M Lykourinas
Journal:  Urol Res       Date:  2004-03-26

3.  Comparison of image quality between conventional and low-dose nonenhanced head CT.

Authors:  Mark E Mullins; Michael H Lev; Peter Bove; Cara E O'Reilly; Sanjay Saini; James T Rhea; James H Thrall; George J Hunter; Leena M Hamberg; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

Review 4.  Multislice CT: update on radiation and screening.

Authors:  Mannudeep K Kalra; Michael M Maher; Sanjay Saini
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

5.  Distinguishing pelvic phleboliths from distal ureteral calculi: thin-slice CT findings.

Authors:  Mehmet Arac; Halil Celik; A Yusuf Oner; Serap Gultekin; Terman Gumus; Sule Kosar
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

6.  Current status of low dose multi-detector CT in the urinary tract.

Authors:  Mi Kim Sung; Sarabjeet Singh; Mannudeep K Kalra
Journal:  World J Radiol       Date:  2011-11-28

7.  Delineation of upper urinary tract segments at MDCT urography in patients with extra-urinary mass lesions: retrospective comparison of standard and low-dose protocols for the excretory phase of imaging.

Authors:  Ulrike L Mueller-Lisse; Eva M Coppenrath; Thomas Meindl; Christoph Degenhart; Michael K Scherr; Christian G Stief; Maximilian F Reiser; Ullrich G Mueller-Lisse
Journal:  Eur Radiol       Date:  2010-08-30       Impact factor: 5.315

8.  The Practice Guidelines for Primary Care of Acute Abdomen 2015.

Authors:  Toshihiko Mayumi; Masahiro Yoshida; Susumu Tazuma; Akira Furukawa; Osamu Nishii; Kunihiro Shigematsu; Takeo Azuhata; Atsuo Itakura; Seiji Kamei; Hiroshi Kondo; Shigenobu Maeda; Hiroshi Mihara; Masafumi Mizooka; Toshihiko Nishidate; Hideaki Obara; Norio Sato; Yuichi Takayama; Tomoyuki Tsujikawa; Tomoyuki Fujii; Tetsuro Miyata; Izumi Maruyama; Hiroshi Honda; Koichi Hirata
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

9.  Low Dose MDCT with Tube Current Modulation: Role in Detection of Urolithiasis and Patient Effective Dose Reduction.

Authors:  Prakashini Koteshwar; Chandan Kakkar; Smiti Sripathi; Anushri Parakh; Rajendra Shrivastav
Journal:  J Clin Diagn Res       Date:  2016-05-01

10.  Low-dose unenhanced CT protocols according to individual body size for evaluating suspected renal colic: cumulative radiation exposures.

Authors:  S Tartari; R Rizzati; R Righi; A Deledda; S Terrani; G Benea
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.